BR112023022270A2 - Enzimas com domínios ruvc - Google Patents

Enzimas com domínios ruvc

Info

Publication number
BR112023022270A2
BR112023022270A2 BR112023022270A BR112023022270A BR112023022270A2 BR 112023022270 A2 BR112023022270 A2 BR 112023022270A2 BR 112023022270 A BR112023022270 A BR 112023022270A BR 112023022270 A BR112023022270 A BR 112023022270A BR 112023022270 A2 BR112023022270 A2 BR 112023022270A2
Authority
BR
Brazil
Prior art keywords
enzymes
ruvc domains
ruvc
domains
distinguishable
Prior art date
Application number
BR112023022270A
Other languages
English (en)
Portuguese (pt)
Inventor
Brian Thomas
Christopher Brown
Cindy Castelle
Cristina Butterfield
S A Goltsman Daniela
Lisa Alexander
Original Assignee
Metagenomi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metagenomi Inc filed Critical Metagenomi Inc
Publication of BR112023022270A2 publication Critical patent/BR112023022270A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112023022270A 2021-04-30 2022-04-29 Enzimas com domínios ruvc BR112023022270A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163182438P 2021-04-30 2021-04-30
PCT/US2022/027124 WO2022232638A2 (en) 2021-04-30 2022-04-29 Enzymes with ruvc domains

Publications (1)

Publication Number Publication Date
BR112023022270A2 true BR112023022270A2 (pt) 2024-01-23

Family

ID=83847352

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023022270A BR112023022270A2 (pt) 2021-04-30 2022-04-29 Enzimas com domínios ruvc

Country Status (10)

Country Link
US (1) US20240110167A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330386A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024517607A (cg-RX-API-DMAC7.html)
KR (1) KR20240004618A (cg-RX-API-DMAC7.html)
CN (1) CN117203332A (cg-RX-API-DMAC7.html)
AU (1) AU2022264921A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023022270A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214222A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023012606A (cg-RX-API-DMAC7.html)
WO (1) WO2022232638A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10913941B2 (en) 2019-02-14 2021-02-09 Metagenomi Ip Technologies, Llc Enzymes with RuvC domains
CN119452085A (zh) 2021-08-27 2025-02-14 宏基因组学公司 具有ruvc结构域的酶
KR20240110603A (ko) 2021-11-24 2024-07-15 메타지노미, 인크. 엔도뉴클레아제 시스템
IL326604A (en) * 2023-09-13 2026-04-01 Metagenomi Therapeutics Inc Engineered and chimeric nucleases
WO2025106934A1 (en) * 2023-11-16 2025-05-22 Metagenomi, Inc. Enzymes with ruvc domains

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105209621B (zh) * 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
US9234213B2 (en) * 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
MX2019011215A (es) * 2017-03-24 2020-02-12 Curevac Ag Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
KR20200124702A (ko) * 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
KR20240007322A (ko) * 2019-02-14 2024-01-16 메타지노미, 인크. Ruvc 도메인이 존재하는 효소
US10913941B2 (en) * 2019-02-14 2021-02-09 Metagenomi Ip Technologies, Llc Enzymes with RuvC domains

Also Published As

Publication number Publication date
AU2022264921A1 (en) 2023-11-23
KR20240004618A (ko) 2024-01-11
EP4330386A2 (en) 2024-03-06
CN117203332A (zh) 2023-12-08
CA3214222A1 (en) 2022-11-03
MX2023012606A (es) 2023-11-03
EP4330386A4 (en) 2025-05-14
US20240110167A1 (en) 2024-04-04
WO2022232638A2 (en) 2022-11-03
WO2022232638A3 (en) 2022-12-01
JP2024517607A (ja) 2024-04-23

Similar Documents

Publication Publication Date Title
MX2022014067A (es) Enzimas con dominios ruvc.
MX2023002913A (es) Enzimas para edicion de bases.
MX2021009886A (es) Enzimas con dominios ruvc.
MX2023012606A (es) Enzimas con dominios ruvc.
MX2024005505A (es) Enzimas de edicion de bases.
MX2022012110A (es) Sistemas crispr clase ii tipo ii.
CL2021000362A1 (es) Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa
EP4028047A4 (en) NOVEL CRISPR-DNA TARGETED ENZYMES AND SYSTEMS
CL2021003242S1 (es) Llanta de vehículo.
MX2024002539A (es) Enzimas con dominios ruvc.
ATE527371T1 (de) Expression löslicher, aktiver, eukaryotischer glucosyltransferasen in prokaryotischen organismen
UY34645A (es) Control de microorganismos fitopatogénicos con pseudomonas sp. y sustancias y composiciones derivad as de las mismas
BR112017003483A2 (pt) composição de enzimas para solubilização de resíduos sólidos municipais, e, processo para solubilizar um resíduo sólido municipal, para produzir um produto de fermentação e para fermentar um resíduo sólido municipal
MX2023014154A (es) Anticuerpos anti-ccr8.
CO2022000422A2 (es) Inhibidores de enzimas
WO2018146557A3 (en) Long double-stranded rna for rna interference
MX2021015301A (es) Métodos de cultivo celular y composiciones para la producción de anticuerpos.
WO2020104649A3 (en) Novel rna compositions and methods for inhibiting angptl8
BR112022010686A2 (pt) Mini-traps de vegf e métodos de uso dos mesmos
PE20200291A1 (es) Glicosidos de esteviol de alta pureza
BR112022003129A2 (pt) Dispositivos e métodos para a detecção de microrganismos usando bacteriófago indicador recombinante deficiente em reprodução
DE602004024686D1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
MX2025010221A (es) Enzimas con dominios ruvc
GB2615901A8 (en) Base editing enzymes
CA3156248A1 (en) ANTI-CD37-MAYTANSINE ANTIBODY CONJUGATES AND METHODS OF USE THEREOF

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: METAGENOMI THERAPEUTICS, INC. (US)

B25G Requested change of headquarter approved

Owner name: METAGENOMI THERAPEUTICS, INC. (US)